Physician oversight and recruitment issues in biosimilar trials, CROs say
Biosimilar clinical trials are increasing but levels of physician oversight and regulatory decisions are still hurdles to overcome, say Parexel, PPD and Vince & Associates.
Archives for November 15, 2013
GE expands cell expansion offering targeting cell therapy firms
GE Healthcare has launched a cell expansion technology designed to win business from cell therapy developers.